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00976.2003.—Rat hearts were perfused with mixtures of [3-13C]pyru-
vate and [3-13C]lactate (to alter cytosolic redox) at low (0.5 mM) or
high (2.5 mM) Ca2 concentrations to alter contractility. Hearts were
frozen at various times after exposure to these substrates, were
extracted, and were then analyzed by 13C NMR spectroscopy. The
time-dependent multiplets observed in the 13C NMR resonances of
glutamate in all hearts and in malate and aspartate in hearts perfused
with high-pyruvate/low-lactate concentrations were analyzed using a
kinetic model of the tricarboxylic acid (TCA) cycle. The analysis
showed that TCA cycle flux (VTCA) and exchange flux (VX) that
involved cycle intermediates were both sensitive to cell redox and
altered Ca2 concentration, and the ratio of these fluxes (VX/VTCA)
varied 10-fold.
13C nuclear magnetic resonance; tricarboxylic acid cycle; intermedi-
ary metabolism; malate-aspartate shuttle; modeling; extracellular cal-
cium concentration
A COMMON ASSUMPTION in early dynamic NMR studies was that
exchange between -ketoglutarate (-KG) and glutamate was
rapid compared with tricarboxylic acid flux (VTCA), and hence
temporal enrichment of glutamate C4 provided a direct readout
of cycle activity. Later kinetic studies of isolated hearts dem-
onstrated that two fluxes, VTCA and exchange flux (VX), are
required to adequately describe the rates of 13C enrichment at
glutamate C4 and C3 (3, 4, 8, 18, 19, 22–26). VX has been
ascribed to an exchange process associated with the malate-
aspartate shuttle in addition to the transaminase exchange (15).
The malate-aspartate shuttle is highly active in cardiac tissue
and thought to be the primary process for transporting reducing
equivalents (NADH) from cytosol to mitochondria (16). The
shuttle consists of the cytosolic and mitochondrial glutamate-
oxaloacetate (OAA) transaminase (GOT) and two transporter
proteins in the inner mitochondrial membrane: the reversible
-KG-malate exchanger and the unidirectional glutamate-as-
partate exchanger (10). It has been shown (15) in isolated
mitochondria that increased Ca2 (6, 9, 20, 21) or H (de-
creased pH) concentration increases the affinity of -KG de-
hydrogenase for -KG and alters mitochondrial levels of
-KG. This in turn has been reported to stimulate aspartate
formation due to less inhibition of aspartate aminotransferase
by -KG and, consequently, overall stimulation of the malate-
aspartate shuttle (21). Thus if VX reflects compartmental ex-
change of glutamate--KG, this working model would predict
that increased Ca2 levels should not only increase contractil-
ity and O2 consumption (and hence VTCA) but increase VX as
well. A positive correlation between VTCA and VX was indeed
observed recently (3) in mouse hearts perfused with various
single substrates, although in this case, the variations in VTCA
and VX were due to differences in the oxidation state of the
substrates presented to the hearts rather than to changes in
extracellular Ca2 concentration ([Ca2]o). VX also increased
significantly in hearts perfused with butyrate upon addition of
lactate (25) purportedly due to increased malate-aspartate shut-
tle activity. More recently, O’Donnell et al. (15) have shown in
isolated rabbit heart mitochondria that lowering the pH results
in a decrease in the Km of -KG dehydrogenase for -KG and
hence a reduced efflux of -KG from mitochondria (reflecting
lower malate-aspartate shuttle activity). This was also reflected
by a lower VX (F1) value measured by NMR in intact hearts
perfused at pH 6.6. These results were consistent with the
hypothesis that direct competition between -KG dehydroge-
nase (Km, 0.10 mM at pH 6.8) and the -KG-malate trans-
porter (Km, 1.5 mM) for mitochondrial -KG is responsible
for the observed decrease in malate-aspartate shuttle activity.
Hence, either increased [Ca2]o or H concentration results in
a decrease of the Km of -KG dehydrogenase, yet Ca2
purportedly stimulates malate-aspartate shuttle activity,
whereas H moderates it. This suggests that the effects of
Ca2 and H differ in mechanistic origin.
In the present study, the temporal evolution of 13C isotopo-
mers in malate, aspartate, and glutamate in perfused hearts
exposed to two different levels of Ca2 and with either high-
lactate/low-pyruvate or high-pyruvate/low-lactate concentra-
tions to alter cytosolic redox was measured in freeze-clamped
tissues by 13C NMR with an aim toward better defining the
metabolic factors that contribute to VTCA and VX. A kinetic
analysis of the data shows that VTCA is influenced more by
changes in [Ca2]o, whereas VX is more sensitive to changes in
cytosolic redox. Interestingly, the VX/VTCA ratio was found to
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be especially sensitive to these physiological variables and
could prove useful as an indicator of tissue physiology.
MATERIALS AND METHODS
Materials. The [3-13C]pyruvate and [3-13C]lactate (99% BC en-
richment) were purchased from Cambridge Isotope Laboratories (An-
dover, MA). All other materials were of the highest quality available
from commercial sources. Male Sprague-Dawley rats (250–300 g)
were obtained from Sasco (Houston, TX).
Heart perfusion. This study was performed under a protocol ap-
proved by the University of Texas Southwestern Animal Care and Use
Committee. After administration of general anesthesia, hearts were
rapidly excised and immersed in cold perfusate. The aorta was
immediately cannulated for retrograde Langendorff perfusion at 100
cm of hydrostatic pressure (14) with a modified Krebs-Henseleit
bicarbonate buffer maintained at 37°C that contained (in mM) 119.2
NaCl, 4.7 KCl, 0.5 (or 2.5) CaCl2, 1.2 MgSO4, and 25 NaHCO3. The
buffer was saturated with 95% O2-5% CO2 and a pH of 7.4 was
maintained. A small latex balloon, which was sutured to one end of a
polyethylene (PE) tube and attached at the other end to a pressure
transducer, was inserted into the left ventricle through the mitral
valve. This balloon enabled the continuous measurement of left
ventricular developed pressure (LVDP) and heart rate (HR) through-
out the experiment. Myocardial O2 consumption (MV˙ O2) was calcu-
lated from the difference in O2 tension (measured with a blood gas
analyzer) between the perfusion medium in the arterial supply line and
the coronary effluent, which was collected via a cannula placed in the
pulmonary artery (13). Coronary flow was measured using a stop-
watch and a graduated cylinder.
Hearts were initially perfused with substrates that contained natu-
ral-abundance levels of 13C to ensure a metabolic steady state (con-
stant pool sizes) before switching to perfusates that contained 13C-
enriched substrates at the same concentrations. Four experimental
perfusate conditions were chosen: 4 mM [3-13C]pyruvate, 0.4 mM
[3-13C]lactate, plus either 0.5 or 2.5 mM Ca2 (groups 1 and 2) and
0.4 mM [3-13C]pyruvate, 4 mM [3-13C]lactate, plus either 0.5 or 2.5
mM Ca2 (groups 3 and 4). After perfusion with 13C-enriched
substrates for varying periods of time, hearts were freeze-clamped
using aluminum tongs precooled in liquid N2. A small portion of
frozen tissue was used for determination of the wet-to-dry ratio by
weighing the tissue before and after slow oven drying. The remainder
of the frozen tissue was pulverized into a fine powder under liquid N2,
extracted in 8% perchloric acid, centrifuged at 15,000 g for 15 min at
4°C, neutralized with KOH, and centrifuged a second time. The
supernatant was freeze-dried, and the lyophilized heart extract was
dissolved in 0.55 ml of 2H2O plus 0.05 ml of a concentrated solution
of EDTA in 2H2O. EDTA was added to remove Ca2 from its citrate
complex so that the C2-C4 resonance of citrate was narrow enough to
allow analysis of isotopomer populations.
13C NMR. Proton-decoupled 13C NMR spectra of heart extracts
(pH measured in 2H2O solutions, 7.2; 25°C) were acquired at 125.7
MHz on a Varian INOVA spectrometer (Varian Instruments; Palo
Alto, CA) using a 5-mm broadband NMR probe, a 45° observed pulse,
and a 3-s delay between pulses. Broadband proton decoupling was
achieved using Waltz decoupling at two power levels: low during the
preacquisition delay and high during acquisition. Relative peak areas
for each multiplet component were determined by deconvolution
using the personal computer-based NMR program NUTS (Acorn; Free-
mont, CA).
Tissue measurements. After acquisition of NMR spectra, samples
were freeze-dried, redissolved in H2O, and assayed for total tissue
aspartate, glutamate, citrate, and malate using standard enzymatic
assays measured spectrophotometrically (1). Appropriate calibration
curves prepared from standards were used to derive metabolite tissue
contents.
Modeling. Metabolite pool sizes and 13C NMR multiplet data were
used as input to a kinetic model of the TCA cycle. The program
tcaFLUX (8), which is an extension of the model reported by Chance
et al. (5), provides a best fit of VTCA, VX, anaplerosis (y), and
fractional enrichment of acetyl-CoA (FC2) to time-dependent 13C
multiplet data (12). The temporal changes in the glutamate C1 doublet
(1D), C2 doublets (D12 and D23), C2 quartet (2Q), C3 doublet and
triplet (3D and 3T), and C4 doublet (D34) were used in the fitting
procedure for hearts perfused with low-pyruvate/high-lactate concen-
trations (other metabolites were not detected with these perfusion
conditions). In addition to these same glutamate multiplets, temporal
data for malate C2 (D23 and Q), malate C3 (D23 and Q), aspartate C2
(D23 and Q), and aspartate C3 (D23 and Q) were also included in the
fitting procedure for hearts perfused with high-pyruvate/low-lactate
concentrations. Dilution of [3-13C]pyruvate/[3-13C]lactate by other
endogenous substrates, expressed as the fraction of acetyl-CoA that is
unenriched (FC0  1  FC2), was also a variable fitted by the kinetic
analysis. All results are presented as means  SD. Differences in
mean values were considered statistically significant at a probability
level of5% (P 0.05). Student’s t-test was used to compare means.
RESULTS
Cardiac performance. HR, LVDP, and MV˙ O2 were mea-
sured for each heart. The rate pressure product (RPP) was not
sensitive to the pyruvate-lactate ratio but was significantly
higher (P  0.0001) at increased [Ca2]o. At 0.5 mM Ca2,
the RPP values were (12  4) 	 103 and (10  4) 	 103
mmHg/min at low- and high-pyruvate concentrations, respec-
tively, and at 2.5 mM Ca2, RPP values were (42  3) 	 103
and (43  5) 	 103 mmHg/min at low- and high-pyruvate
concentrations, respectively. MV˙ O2 values also increased sig-
nificantly between the low- and high-[Ca2]o groups as ex-
pected. Interestingly, MV˙ O2 was also higher between the low-
vs. high-pyruvate groups with either 0.5 or 2.5 mM Ca2 in the
perfusate.
Tissue levels of TCA cycle intermediates. The most abun-
dant metabolite in hearts perfused with a mixture of 0.4 mM
[3-13C]pyruvate and 4.0 mM [3-13C]lactate was glutamate
(Table 1). The tissue contents of other cycle intermediates
and aspartate were small and could therefore be neglected in
the kinetic analysis (22). Tissue glutamate content tended to
decrease at higher [Ca2]o (20.4  5.3 vs. 17.5  4.2

mol/g dry wt at 0.5 vs. 2.5 mM Ca2, respectively) but did
not reach statistical significance. The metabolite content of
hearts perfused with 4.0 mM [3-13C]pyruvate and 0.4 mM
[3-13C]lactate was, however, quite different; glutamate con-







Glutamate Aspartate Malate Citrate
0.1 0.5 20.45.3
0.1 2.5 17.54.2
10 0.5 4.81.6* 3.60.5* 2.70.7* 3.60.3
10 2.5 6.60.9* 8.11.3* 4.60.9* 3.60.3
Values are means  SD; n  15 hearts in each extracellular Ca2
concentration ([Ca2]o) group. Metabolite contents were measured by enzy-
matic assay. A [3-13C]pyruvate-to-[3-13C]lactate ratio of 0.1 refers to hearts
perfused with 0.4 mM [3-13C]pyruvate and 4.0 mM [3-13C]lactate; ratio of 10
refers to hearts perfused with 4.0 mM [3-13C]pyruvate and 0.4 mM [3-13C]lac-
tate. *P  0.05 for respective 0.5 vs. 2.5 mM [Ca2]o groups.
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tent was lower, whereas citrate, malate, and aspartate were
all present in significant amounts (Table 1). With this
substrate mix, a increase in [Ca2]o from 0.5 to 2.5 mM did
produce significant increases in glutamate content (4.8 
1.6 vs. 6.6  0.9 
mol/g dry wt), aspartate (3.6  0.5 vs.
8.1  1.3 
mol/g dry wt), and malate (2.7  0.7 vs. 4.6 
0.9 
mol/g dry wt). Thus an increase in the pyruvate-lactate
ratio from 0.1 (typical of physiological conditions) to 10
resulted in an approximately fourfold reduction in tissue
glutamate level at low [Ca2]o (from 20.4  5.3 to 4.8  1.6

mol/g dry wt) and an approximately threefold reduction at
high [Ca2]o (from 17.5  4.2 to 6.6  0.9 
mol/g dry wt)
and concomitant increases in aspartate, malate, and citrate
(Table 1).
13C NMR spectra. The [3-13C]pyruvate and [3-13C]lactate
(after conversion to pyruvate) are avidly oxidized by heart
tissue first via conversion to [2-13C]acetyl-CoA at the level of
pyruvate dehydrogenase and subsequently via the TCA cycle.
Condensation of [2-13C]acetyl-CoA with OAA on each turn of
the cycle results in the entry of 13C into all cycle intermediates
and metabolites derived from those intermediates. After mul-
tiple cycle turns, each metabolite resonance appears as multi-
plets largely due to one-bond 13C-13C spin-spin couplings.
Figure 1 shows expanded aliphatic regions (10–80 ppm) of
13C spectra of heart extracts after perfusion to steady state with
either 4.0 mM [3-13C]pyruvate and 0.4 mM [3-13C]lactate or
0.4 mM [3-13C]pyruvate and 4.0 mM [3-13C]lactate, both at
low [Ca2]o. In Fig. 1A (high-pyruvate/high-lactate concentra-
tions), the resonances of glutamate, aspartate, malate, and
citrate all appear as multiplets, whereas in Fig. 1B (low-
pyruvate/low-lactate concentrations), only glutamate was de-
tected. A significant amount of [3-13C]alanine (a singlet) was
also evident in spectra of hearts perfused with high-pyruvate/
high-lactate concentrations, which reflects the high intracellu-
lar content of [3-13C]pyruvate.
Figure 2 illustrates the temporal evolution of several multi-
plet components (glutamate C4D34, aspartate C3D23 and
C3Q, and malate C3D23 and C3Q) for hearts perfused with
Fig. 1. 125.7-MHz 13C NMR spectra of ex-
tracts from rat hearts perfused with 4.0 mM
[3-13C]pyruvate plus 0.4 mM [3-13C]lactate
(A) or 0.4 mM [3-13C]pyruvate plus 4.0 mM
[3-13C]lactate (B), both in the presence of
low (0.5 mM) extracellular Ca2 concentra-
tion ([Ca2]o). Aside from glutamate car-
bons (Glu-C2, Glu-C3, and Glu-C4), expan-
sions in A also show (left to right) citrate C3
(Cit-C3), malate C2 (Mal-C2), aspartate C2
(Asp-C2), citrate C2 and C4 (Cit-C2C4),
malate C3 (Mal-C3), and aspartate C3 (Asp-
C3). Expansions in B refer to glutamate
carbons C2 (Glu-C2), C3 (Glu-C3), and C4
(Glu-C4).
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high-pyruvate/low-lactate concentrations at 0.5 and 2.5 mM
[Ca2]o. Similar graphs were obtained for hearts perfused with
low-pyruvate/high-lactate concentrations, but in this case, only
glutamate multiplets were detected. As indicated above,
changes in the pyruvate-lactate ratio result in considerable
redistribution of metabolite contents, and this makes a dramatic
difference in the temporal evolution of the 13C multiplets
(evolution of isotopomer populations). Hearts perfused with
high vs. low [Ca2]o were freeze-clamped at different time
intervals (as noted in Fig. 2) to account for differences in TCA
cycle kinetics in these two groups. Metabolic steady state was
reached after30 min in hearts perfused with 2.5 mM [Ca2]o
and after 45 min in hearts perfused with 0.5 mM [Ca2]o.
Kinetic analysis of isotopomer data. A kinetic analysis of the
time-dependent 13C-multiplet areas yielded values for VTCA
and VX as summarized in Table 2 (values in parentheses are
5–95% confidence limits for each flux). The fractional contri-
bution of lactate plus pyruvate to acetyl-CoA (FC2) was iden-
tical in all groups: when supplied with low-pyruvate/high-
lactate concentrations, their contribution was 0.88 (0.85–0.90)
at low [Ca2]o and 0.89 (0.87–0.92) at high [Ca2]o; when
perfused with high-pyruvate/low-lactate concentrations, at low
[Ca2]o, the value was 0.90 (0.88–0.92) and at high [Ca2]o,
it was 0.92 (0.90–0.95). An increase in [Ca2]o from 0.5 to 2.5
mM resulted in an approximately twofold increase in VTCA for
both the low-and high-pyruvate groups. Similarly, an increase
in [Ca2]o resulted in a VX increase of approximately threefold
for the low-pyruvate group and nearly fourfold for the high-
pyruvate group. Changing the substrate presented to hearts
from a low- to a high-pyruvate concentration resulted in only
small increases in VTCA (1.4-fold), whereas VX decreased
four to fivefold. Similar trends in VTCA and VX were obtained
by analysis of the temporal changes in glutamate C4D34 alone
(Table 3).
It has been suggested that inclusion of additional 13C mul-
tiplet data from intermediates such as malate and aspartate in a
kinetic analysis may provide more reliable evaluations of VTCA
and VX compared with inclusion of glutamate data alone (4). A
separate kinetic fitting of glutamate C4D34 multiplet data
alone yielded similar average values for VTCA and VX (Table 3)
as those obtained by analysis of multiplet data from all visible
metabolites (see Table 2), although three of the total of eight
flux measurements fell outside the 5–95% confidence range
established by the more-complete analysis. As anticipated, the
confidence levels were about twofold larger on average for the
glutamate C4D34 fits alone. The one exception was the value
of VX for the high-pyruvate/low-lactate groups, where the
5–95% confidence spread in VX was smaller when glutamate
Fig. 2. Temporal evolution of 13C NMR multiplet components for glutamate,
aspartate, and malate in hearts perfused with 4.0 mM [3-13C]pyruvate plus 0.4
mM [3-13C]lactate in the presence of either 0.5 mM (solid line) or 2.5 mM
(dotted line) [Ca2]o. Curves for aspartate and malate approach one another for
both C3D23 and C3Q, reflecting similar kinetics of 13C appearance in these
two metabolites. Evolution of the C4D34 of glutamate is slower, reflecting
either a slow exchange with tricarboxylic acid cycle intermediates or a dilution
of the 13C labeling by the large glutamate cytosolic pool. An increase in
[Ca2]o caused an increase in the rate of 13C incorporation for all metabolites.
Table 2. O2 consumption and fluxes as determined by kinetic analysis of NMR isotopomer data from glutamate, aspartate,
and malate
Pyruvate-to-Lactate Ratio [Ca2]o, mM
MV˙ O2,

mol  min1  g dry wt1
VTCA,

mol  min1  g dry wt1
VX,

mol  min1  g dry wt1 VX/VTCA
0.1 0.5 11.12.1* 3.21 (2.77–3.60) 6.68 (4.40–9.46) 2.0
0.1 2.5 21.53.7* 6.55 (5.83–7.14) 18.0 (11.9–27.0) 2.7
10 0.5 14.52.2* 4.41 (4.23–4.59) 1.27 (0.25–1.71) 0.3
10 2.5 27.33.5* 8.48 (8.11–8.87) 4.79 (3.54–6.48) 0.6
Values are means  SD; 5–95% confidence limits are shown in parentheses. VTCA, tricarboxylic acid cycle flux; VX, exchange flux. MV˙ O2 (myocardial O2
consumption) was significantly different between the low- (0.05 mM) and high- (2.5 mM) Ca2 groups and between the low-pyruvate/high-lactate (0.1) and the
high-pyruvate/low-lactate (10) groups. *P  0.001.
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C4D34 was fitted alone. This is more a reflection of the lower
concentration of glutamate. A significant difference in flux
values was found only for the low-pyruvate/high-lactate, high-
[Ca2]o group, where VX was poorly defined using glutamate
C4D34 alone. This is also the group that showed the greatest
disparity between VX and VTCA values, which suggests that the
glutamate C4D34 describes the kinetics well whenever VX and
VTCA are similar in magnitude and the extra multiplet data add
substantially to the fit whenever there is the greatest disparity
between these flux values.
DISCUSSION
Tissue metabolites. Exposure of hearts to different ratios of
pyruvate and lactate (with total concentrations held constant at
4.4 mM) alters the cytosolic redox state and subsequently the
steady-state levels of several tissue metabolites (see Table 1).
One should note that these changes do not result from a change
in tissue pH, because even the highest level of lactate used here
(4 mM) does not exceed the buffering capacity of the tissue.
Rather, these changes must originate from changes in the redox
state of the tissue (11).
A 10-fold increase in pyruvate from 0.4 to 4 mM would
predictably decrease cytosolic NADH and increase cytosolic
NAD. This in turn should favor formation of OAA from
malate (via cytosolic malate dehydrogenase) and subsequent
conversion of OAA to aspartate and -KG to glutamate (via
the transaminase GOT). This would result in a net shift in
the tissue content of many TCA cycle and related interme-
diates (aspartate, malate, and citrate). This was observed
experimentally at both high and low [Ca2]o, although it is
interesting to note that there was a net decrease in total
tissue metabolites in the low-[Ca2]o group as pyruvate was
increased from 0.4 to 4 mM (20.4  5.3 vs. 14.7  3.0

mol/g dry wt) and a net increase in total tissue metabolites
in the high-[Ca2]o group as pyruvate was increased from
0.4 to 4 mM (17.5  4.2 vs. 22.9  3.3 
mol/g dry wt). This
demonstrates that [Ca2]o does indeed have a significant
effect on total tissue metabolite levels, although the effect is
more evident when the metabolites are more evenly distrib-
uted among glutamate, aspartate, malate, and citrate (high-
pyruvate group).
An increase in [Ca2]o from 0.5 to 2.5 mM had a more
subtle effect on tissue metabolites (see Table 1). With an
increase in [Ca2]o, tissue metabolites (mostly glutamate)
tended to be lower in the low-pyruvate group but clearly
increased in the high-pyruvate group. Here the observed
changes in metabolite levels are not as easily predicted based
on shifts in known equilibria, but studies of isolated mitochon-
dria have demonstrated that mitochondrial Ca2 content,
which is known to increase with an increase in [Ca2]o,
significantly decreases the Km of -KG dehydrogenase and
thereby lowers mitochondrial -KG (21). This in turn should
increase mitochondrial aspartate and decrease mitochondrial
OAA and glutamate contents.
Influence of altered Ca2 on TCA cycle kinetics. An increase
in [Ca2]o is known to increase both contractility (2) and
MV˙ O2 (22). In these Langendorff-perfused hearts, an increase
in [Ca2]o from 0.5 to 2.5 mM resulted in an approximately
twofold increase in MV˙ O2. This was also detected in our
kinetic analyses as an increase in VTCA (approximately two-
fold) between the low- vs. high-Ca2 groups for both low-
pyruvate and high-pyruvate groups. It was found that VX was
also stimulated at higher Ca2 levels, and, in fact, VX was
about twice as sensitive to the fivefold increase in [Ca2]o as
was VTCA. The origin of this effect is unknown. It has been
reported that increases in [Ca2]o stimulate both glycolysis and
glucose oxidation by direct stimulation of phosphofructoki-
nase-1 and pyruvate dehydrogenase by Ca2 (17), but glucose
was not present in these experiments, so the increase in VX
must have a different origin. Perhaps it is related to the increase
in contractility and O2 demand that is produced by increased
[Ca2]o. It has been proposed that VX reflects an exchange
between -KG and glutamate (15), which in turn could reflect
an increase in the malate-aspartate shuttle activity (21). Hence,
higher [Ca2]o may stimulate the shuttling of more reducing
equivalents from the cytosol into the mitochondria to contrib-
ute to the increased O2 demand. In the present experiments,
these reducing equivalents would most likely be contributed by
cytosolic lactate, but unfortunately, we cannot differentiate
between oxidation of pyruvate vs. oxidation of lactate because
both substrates were labeled with 13C equivalently. It is inter-
esting to note, however, that the change in VX with increased
O2 demand (low- vs. high-[Ca2]o groups) was much higher
when the cytosol was more reduced (pyruvate-lactate ratio, 0.1).
Influence of changes in cytosolic redox on TCA cycle kinet-
ics. One would anticipate that altering cytosolic redox by
changing the pyruvate-lactate ratio would have predictable
effects on both VTCA and VX. As a first approximation, one
would anticipate that high-lactate (low-pyruvate) concentration
would stimulate the malate-aspartate shuttle (25), and hence,
more reducing equivalents would be transported from the
cytosol into the mitochondria. Indeed, VX was about four- to
fivefold higher in hearts perfused with low-pyruvate/high-
lactate concentrations at both levels of [Ca2]o. Furthermore,
import of more reducing equivalents from the cytosol into the
mitochondria should also decrease the requirement of the TCA
cycle to produce NADH; hence, one would expect that VTCA
would be lower. This was also detected by the kinetic analysis
and by a direct measure of MV˙ O2. As shown in Table 2, both
VTCA and MV˙ O2 increased significantly between the low-
Table 3. Fluxes as determined by kinetic analysis of glutamate C4D34 alone
Pyruvate-to-Lactate Ratio [Ca2]o, mM
VTCA

mol  min1  g dry wt1
VX

mol  min1  g dry wt1 VX/VTCA
0.1 0.5 3.41 (2.66–3.74)* 7.73 (3.78–12.84)* 2.3
0.1 2.5 6.98 (6.48–8.04)* 31.5 (17.7–100)* 4.5
10 0.5 3.50 (3.30–3.85)* 1.69 (1.67–1.84)* 0.5
10 2.5 6.90 (6.38–7.59)* 5.78 (5.77–6.35)* 0.8
Values are means  SD; 5–95% confidence limits are shown in parentheses. *P  0.05, significantly different fluxes.
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pyruvate/high-lactate group compared with the high-pyruvate/
low-lactate group (at both low and high [Ca2]o), although
contractile function as measured by RPP did not change at
either [Ca2]o level. The percent increases in MV˙ O2 between
the low- and high-pyruvate groups were similar for hearts
perfused with 0.5 mM (23% increase) vs. 2.5 mM (21%
increase) [Ca2]o. This indicates that the increase in MV˙ O2 is
not related to increased demand brought about by the increased
contractility promoted by Ca2 but is rather due to the sub-
strates available to the heart. It has been observed in a perfused,
working heart preparation that switching the perfusate sub-
strate available to hearts from glucose to pyruvate can result in
an increase in MV˙ O2 without a concomitant increase in RPP
(7). Yu et al. (25) also found that VX (equivalent to F1 in Ref.
25) increased by four- to fivefold in hearts perfused with
butyrate plus lactate compared with butyrate alone, whereas
VTCA was no different in these two groups. They also found no
net oxidation of lactate; however, we observed net oxidation of
lactate (FC2 values, 0.9 for all groups). These differences
likely reflect the expected differences in mitochondrial redox
state between hearts perfused with pyruvate vs. butyrate.
Comparisons to previous studies. The primary role of the
TCA cycle in heart tissue is to provide reducing equivalents
for electron transport and subsequent ATP synthesis. The
values reported here for VTCA are significantly smaller than
the values reported previously for acetate-perfused hearts
but are similar to the values reported for acetate- plus
propionate-perfused hearts (4). Although acetate has a sin-
gle metabolic fate in the heart (to contribute to acetyl-CoA
and generate reducing equivalents in the TCA cycle), both
lactate and pyruvate are capable of contributing extra re-
ducing equivalents and thus reducing VTCA. Perfusion of
hearts with any substrate or substrate mixture that contrib-
utes reducing equivalents external to the TCA cycle results
in lower cycle flux relative to hearts perfused with acetate
alone. This trend was observed by Burgess et al. (3) in
mouse hearts, where it was found that VTCA was signifi-
cantly higher in hearts perfused with acetate alone vs.
octanoate alone and vs. lactate alone (27.1 vs. 17.1 vs. 13.1

mol  min1  g dry wt1, respectively). Jeffrey et al. (8)
also observed a similar trend in rat hearts perfused with
glucose plus acetate vs. glucose plus pyruvate, where VTCA
decreased from 11.3 to 6.1 
mol  min1  g dry wt1.
The observations that a more highly oxidized cytosol results
in an increase in VTCA and a decrease in VX whereas an
increase in [Ca2]o results in an increase in both VTCA and VX
are at least consistent with a parallel between VX and malate-
aspartate shuttle activity. However, it is clear from these and
other experiments that the process represented by VX does not
require net transport of reducing equivalents from the cytosol
to the mitochondria under all conditions, so VX may be more
accurately described as a metabolite-exchange flux across the
inner mitochondrial membrane (15). The VX/VTCA ratio (see
Tables 2 and 3) was found to vary 10-fold among the four
groups of hearts reported here (0.3 for hearts perfused with
low-[Ca2]o and high-pyruvate concentrations to 2.7 for hearts
perfused with high-[Ca2]o and low-pyruvate concentrations),
so the ability of the heart to alter both VTCA and VX reflects an
intricate coordination of energy demand and exchange kinetics.
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